• About
  • Subscribe
  • Advertise
  • Contact
Thursday, December 5, 2024
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Events Conferences International

Chinese myopia-lockdown study a portent for Australia

by rhiannon bowman
January 20, 2021
in International, Local, News, Ophthalmology, Optometry, Research
Reading Time: 4 mins read
A A
Unanswered questions in myopia management will be addressed at O=MEGA23/WCO4 in September.

Unanswered questions in myopia management will be addressed at O=MEGA23/WCO4 in September.

Share on FacebookShare on Twitter

A new phenomenon dubbed “quarantine myopia” is making waves in Australia in the wake of a Chinese study that found myopia prevalence was three times higher in six-year-olds during the COVID-19 pandemic.

The cross-sectional study tested 123,535 children and found a substantial myopic shift (−0.3 diopters) for children aged six to eight years after home confinement due to coronavirus.

The study and related editorial published in JAMA Ophthalmology noted the prevalence of myopia appeared to be approximately three times higher in 2020 than in other years for children aged six, two times higher for seven-year-olds, and 1.4 times higher for those aged 8.

Such a substantial increase was not seen in older age groups (9-13 years), despite being offered more intense daily online learning courses. The researchers state this may indicate younger children’s refractive status may be more sensitive to environmental changes.

According to Optometry Australia (OA) chief clinical officer Mr Luke Arundel, the findings were important because children worldwide had done months of home schooling, including in Australia where schools were closed and sport cancelled.

“Researchers have told us for many years now the importance of balancing screen time with green time for kids and that spending time outside in bright light is important to slow myopia development and progression,” Arundel said in an article on the OA website.

“It will be interesting to see if Australian practitioners, particularly in Victoria – where an extended lockdown occurred with time outside limited to just one hour a day – will also see a similar increase in myopia.”

Although Australia does not have the scientific evidence to substantiate the effects of quarantine on children’s eyesight yet, there is growing anecdotal evidence that myopia progression is accelerating here.

In an interview with Insight in December, Dr Philip Cheng, director of The Myopia Clinic in Melbourne, said he noticed a drastic rise in myopia during the final six months of 2020.

Melbourne optometrist Dr Philip Cheng says myopia progression has worsened during the pandemic.

“I’m seeing more children diagnosed with myopia for the first time, young kids with high myopia who have progressed rapidly, and at-risk children with axial length increase. I’ve seen a discernible change, which I think is environmental, as a result of the extended Stage 4 lockdowns in metropolitan Melbourne,” he said.

Like Cheng’s clinic in inner-Melbourne, optometrist Ms Jessica Chi at Eyetech Optometrists in Carlton also noticed an increase in myopia progression last year in patients who had been otherwise stable.

“Generally speaking, we’re seeing more kids with myopia now than in the past – not just East Asian kids but now Caucasian kids too. And after seven months of lockdown in Melbourne, we’re seeing more myopia progression. Why? Kids are spending less time outdoors and more time on screens during home-schooling,” Chi said.

Ms Susan Ang, owner of Eyestore with practices in Bankstown in Sydney, and Kiama, south of Wollongong, said she has noticed myopia progression accelerating amongst her predominantly Asian patient base in her Bankstown practice.

Ms Susan Ang, Eyestore.

She said NSW had six weeks of school lockdown last year, and with parents working from home on devices up to 10 hours a day, kids followed suite.

“I saw a child in February before the practice was closed during lockdown. We re-opened in May and the child came in for their three-month review. The increase in diopters I would normally see over the course of a year, I saw in six months,” she said.

She said kids that were following a myopia management treatment plan fared better than those opting for single-vision correction or no correction.

“For the patients under my care, those on atropine 0.05% fared the best in combination with orthokeratology, bifocal, or multifocal vision correction,” she said.

“It has fortified my view that some treatment is better than none.”

Ang said the “quarantine myopia” phenomenon was an emerging topic of discussion on Australian optometry forums, with practitioners raising concerns about the rate of change in dioptres among their myopia patients.

“It’s palpable, you can feel that increase,” she said.

The study ‘Progression of Myopia in School-Aged Children After COVID-19 Home Confinement’ can be found here.

More reading

Spectacles the most common myopia approach for Aussie optometrists

Tools, training, time: The pillars to myopia care

Kids, contact lenses and compliance 

Tags: COVID-19DR PHILIP CHENGJAMA OphthalmologyMyopiaOptometry Australiapandemicprevelenceprogressionquarantine myopia

Related Posts

A new WA clinic will give Aboriginal communities and others greater access to eyecare. Image: Sawoon/stock.adobe.com

New clinic will help address inequities in Aboriginal eyecare

by Staff Writer
December 5, 2024

A new eye clinic aims to make a significant impact in transforming eyecare for Aboriginal communities in Western Australia. A...

Or lack of it, depending on where you live, is the concern of the CPMC and others. Image: BJP7images/stock.adobe.com.

Health ministers warned that fast-track changes could bring ‘postcode’ health care

by Staff Writer
December 5, 2024

Australia’s state health ministers have been warned that the proposed fast-track registration of Specialist International Medical Graduates (SIMGs) risks exacerbating...

Alcon has confirmed its new Unity systems are now registered in Australia, and will be commercially available in 2025. Image: Konektus Photo/Shutterstock.com.

All-new Alcon Unity vitreoretinal and cataract systems approved in Australia

by Myles Hume
December 4, 2024

Alcon has revealed its “highly anticipated” Unity Vitreoretinal Cataract System and Unity Cataract System have been included on the Australian...

Join our newsletter

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited